A Study of HM10560A in Healthy Male Subject

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

March 31, 2010

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Healthy
Interventions
DRUG

HM10560A

Subcutaneously administrate at 0 hour on Day 1

DRUG

Placebo

Placebo

Trial Locations (1)

Unknown

Medical Center, Seoul

All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01093742 - A Study of HM10560A in Healthy Male Subject | Biotech Hunter | Biotech Hunter